DOCOX: A phase II trial with docetaxel and oxaliplatin as a second-line systemic therapy for patients with advanced and/or metastatic adenocarcinoma of the pancreas.
Thomas Jens Ettrich
Research Funding - Sanofi
Other Remuneration - Sanofi
Goetz von Wichert
No relevant relationships to disclose
Thomas M. Gress
No relevant relationships to disclose
Patrick Michl
No relevant relationships to disclose
Michael Geissler
No relevant relationships to disclose
Holger Frithjof Hebart
No relevant relationships to disclose
Andreas W. Berger
No relevant relationships to disclose
Marc Porzner
No relevant relationships to disclose
Bettina Danner
No relevant relationships to disclose
Rainer Muche
No relevant relationships to disclose
Thomas Seufferlein
Honoraria - Sanofi
Research Funding - Sanofi